|
ESD expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.639620E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.775200E-04 |
| Normal-vs-Stage2 |
3.808400E-01 |
| Normal-vs-Stage3 |
4.264000E-02 |
| Normal-vs-Stage4 |
8.714200E-01 |
| Stage1-vs-Stage2 |
2.624800E-01 |
| Stage1-vs-Stage3 |
2.75819999995264E-06 |
| Stage1-vs-Stage4 |
9.689700E-02 |
| Stage2-vs-Stage3 |
4.114000E-02 |
| Stage2-vs-Stage4 |
4.880000E-01 |
| Stage3-vs-Stage4 |
3.481000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.030610E-01 |
| Normal-vs-AfricanAmerican |
4.008600E-01 |
| Normal-vs-Asian |
1.331960E-02 |
| Caucasian-vs-AfricanAmerican |
8.999900E-02 |
| Caucasian-vs-Asian |
1.993030E-01 |
| AfricanAmerican-vs-Asian |
3.782000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.101600E-01 |
| Normal-vs-Female |
8.756100E-02 |
| Male-vs-Female |
3.869600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.609600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.078760E-01 |
| Normal-vs-Age(61-80Yrs) |
4.841000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.672200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.845600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.325800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.301800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.538400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.815400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.447800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.461570E-03 |
| Normal-vs-Grade 2 |
2.16279999999403E-05 |
| Normal-vs-Grade 3 |
9.153000E-01 |
| Normal-vs-Grade 4 |
4.036200E-02 |
| Grade 1-vs-Grade 2 |
2.320000E-01 |
| Grade 1-vs-Grade 3 |
1.401020E-03 |
| Grade 1-vs-Grade 4 |
7.83080000000824E-05 |
| Grade 2-vs-Grade 3 |
2.186400E-04 |
| Grade 2-vs-Grade 4 |
2.786500E-04 |
| Grade 3-vs-Grade 4 |
5.205800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.54791801177635E-15 |
| Normal-vs-ccB subtype |
2.48329999996688E-06 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.014200E-01 |
| Normal-vs-N1 |
2.680500E-02 |
| N0-vs-N1 |
2.072500E-02 |
|
|
